Skip to main content
BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.232
+0.019 (8.97%)
At close: Mar 9, 2026, 4:00 PM EDT
0.228
-0.004 (-1.90%)
After-hours: Mar 9, 2026, 5:53 PM EDT

BioRestorative Therapies Revenue

BioRestorative Therapies had revenue of $11.80K in the quarter ending September 30, 2025, a decrease of -94.95%. This brings the company's revenue in the last twelve months to $383.40K, up 1.70% year-over-year. In the year 2024, BioRestorative Therapies had annual revenue of $401.00K with 175.03% growth.

Revenue (ttm)
$383.40K
Revenue Growth
+1.70%
P/S Ratio
12.06
Revenue / Employee
$34,855
Employees
11
Market Cap
4.97M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024401.00K255.20K175.03%
Dec 31, 2023145.80K26.00K21.70%
Dec 31, 2022119.80K73.80K160.43%
Dec 31, 202146.00K-31.00K-40.26%
Dec 31, 202077.00K-53.00K-40.77%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
GeoVax Labs 3.35M
Xenetic Biosciences 2.86M
VivoSim Labs 142.00K
Bio Green Med Solution 81.00K
Silo Pharma 72.10K
Revenue Rankings

BRTX News

More News